Results 111 to 120 of about 25,533 (219)

Introducing auto-disable syringes to the national immunization programme in Madagascar

Bulletin of the World Health Organization, 2003
OBJECTIVE: To evaluate the safety and coverage benefits of auto-disable (AD) syringes, weighed against the financial and logis- tical costs, and to create appropriate health policies in Madagascar.
Drain Paul K., Ralaivao Josoa S., Rakotonandrasana Alexander, Carnell Mary A.   +3 more
doaj  

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids. [PDF]

, 2019
Tramadol is one of the most commonly used analgesics worldwide, classified as having a low abuse potential by U.S. Drug Enforcement Agency, and often recommended in pain management guidelines.
Abagyan, Ruben, Atayee, Rabia S, Makunts, Tigran, U, Andrew   +3 more
core   +1 more source

Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational study

Vaccine: X
In Veneto Region, HPV vaccine has been actively offered to 12 year-old females since 2008, and to 12 year-old males since 2015. The study aims to analyze the safety profile of HPV4v and HPV9v vaccines and perform a case-by-case review of conditions of ...
Diana Dalla Valle, Roberto Benoni, Nicola Soriolo, Chiara Battistella, Francesca Moretti, Laura Augusta Gonella, Stefano Tardivo, Silvia Colpo, Sara Montresor, Francesca Russo, Michele Tonon, Filippo Da Re, Ugo Moretti, Giovanna Zanoni   +13 more
doaj  

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON [PDF]

, 2016

core   +1 more source

Authorisation and Withdrawal of Pharmaceutical Innovations in the European Union and in the United States (1995-2003) [PDF]

This is a comparative study of the average and median approval times for pharmaceutical innovations (new molecular entities -NMES- and new biologics), authorised in the United States (US) and in the European Union (EU) under the centralised procedure ...
Cabiedes Miragaya, Laura
core  

Incentivizing Postmarketing Pharmaceutical Product Safety Testing with Extension of Exclusivity Periods [PDF]

, 2008
Kushner, Leslie
core   +1 more source

Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium. [PDF]

Gut
Tseng CH, Wong S, Yu J, Lee YY, Terauchi J, Lai HC, Luo JC, Kao CY, Yu SL, Liou JM, Wu DC, Hou MC, Wu MS, Wu JJ, Sung JJY, El-Omar EM, Wu CY.   +16 more
europepmc   +1 more source

Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis. [PDF]

Lupus Sci Med
Li H, Xie W, Wang C, Guo C.
europepmc   +1 more source

Postmarketing surveillance does not catch all adverse events

British medical journal, 1996
P. O'Brien
semanticscholar   +1 more source

A multicenter, postmarketing surveillance of elobixibat in patients with chronic constipation in Japan: A final analysis report. [PDF]

SAGE Open Med
Nakajima A, Umeyama M, Higashikawa M, Shimada Y, Arai Y.   +4 more
europepmc   +1 more source